Camp4 Therapeutics CORP (CAMP) — 8-K Filings

All 8-K filings from Camp4 Therapeutics CORP. Browse 12 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (12)

Camp4 Therapeutics Files 8-K on Officer/Director Changes — Mar 24, 2026
Camp4 Therapeutics Corp filed an 8-K on March 24, 2026, reporting an event that occurred on March 18, 2026, under Item 5.02, which typically covers changes in d
Camp4 Therapeutics Corp. Enters and Terminates Agreements — Dec 23, 2025 Risk: medium
On December 22, 2025, Camp4 Therapeutics Corp. entered into a material definitive agreement and terminated a material definitive agreement. The filing does not
8-K Filing — Dec 18, 2025
Camp4 Therapeutics Corp. Files 8-K for Material Agreement — Dec 18, 2025 Risk: medium
On December 18, 2025, Camp4 Therapeutics Corp. entered into a material definitive agreement. The filing also includes financial statements and exhibits related
Camp4 Therapeutics Files 8-K — Oct 1, 2025 Risk: low
On October 1, 2025, Camp4 Therapeutics Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update r
Camp4 Therapeutics Files 8-K: Material Agreement, Equity Sales — Sep 10, 2025 Risk: medium
On September 9, 2025, Camp4 Therapeutics Corp. entered into a material definitive agreement, details of which are not fully disclosed in this filing. The compan
Camp4 Therapeutics Files 8-K on Shareholder Vote Matters — Jun 13, 2025 Risk: low
Camp4 Therapeutics Corporation filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of security holders on June 11, 2025. The filing details
Camp4 Therapeutics Files 8-K — May 16, 2025 Risk: low
Camp4 Therapeutics Corp. filed an 8-K on May 16, 2025, to report current information. The filing does not disclose specific material events, financial statement
Camp4 Therapeutics Corp. Announces CSO Departure, Director Changes — Mar 18, 2025 Risk: medium
Camp4 Therapeutics Corp. announced on March 12, 2025, the departure of Dr. Jonathan Fleming from his role as Chief Scientific Officer. The company also reported
8-K Filing — Jan 7, 2025
Camp4 Therapeutics Files 8-K on Financials — Nov 21, 2024 Risk: low
Camp4 Therapeutics Corp. filed an 8-K on November 21, 2024, reporting on its results of operations and financial condition. The filing provides information rega
Camp4 Therapeutics Files 8-K — Oct 15, 2024 Risk: low
Camp4 Therapeutics Corporation filed an 8-K on October 15, 2024, reporting amendments to its articles of incorporation or bylaws and financial statements. The c

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX